Sinocare

Sinocare is a high-tech company that employs biosensing technology to develop, produce, and sell rapid diagnostic test products for chronic diseases, serving chronic disease patients and healthcare professionals. It also provides professional services and digital health management solutions for diabetes. Founded in 2002 in Changsha, China, Sinocare acquired Nipro Diagnostic Inc. (now Trividia Health Inc.) and PTS Diagnostics Inc. in 2016. It operates 9 global R&D and manufacturing sites and has a presence in 187 countries and regions.

Sinocare was founded in 2002 in Changsha, China. From the outset, it has dedicated itself to providing innovative, high-quality products and services to people with diabetes and other chronic diseases. In 2016, Sinocare acquired Nipro Diagnostic Inc. (now renamed Trividia Health Inc.) and PTS Diagnostics Inc., marking its entry into the global elite circle of the blood glucose meter industry. As of the official website, in China, more than 50% of diabetics use Sinocare products for self-monitoring. Sinocare has 9 global R&D and manufacturing sites and ranks first in China and fourth worldwide in the blood glucose monitoring market.

• 2016

  Acquired Nipro Diagnostic Inc. (now Trividia Health Inc.) and PTS Diagnostics Inc., marking entry into the global elite circle of the blood glucose meter industry.

• 2002

  Sinocare founded in Changsha, China.

• Became China's first listed company of blood glucose meter.

• Reached 9 global R&D and manufacturing sites, presence in 187 countries and regions, and 25,000+ K global users.

• Accumulated 780+ authorized patents.

• Launched iCan Continuous Glucose Monitoring System.

The Leading Diabetes Digital Management Expert in the World

• iCan Continuous Glucose Monitoring System

• Safe AQ Series

• Safe-Accu2

• Safe-Accu

• 2026

  U.S. subsidiary's glucose meters classified by FDA as Class I recall

  The TRUE METRIX series blood glucose meters of Trividia, a U.S. subsidiary of Sinocare, have an E-5 error code that indicates both “very high blood glucose” and “test strip error,” which may delay recognition of hyperglycemia; FDA issued an alert and classified it as a Class I recall, with related reports covering 114 injuries and 1 death; the company said the products did not directly cause them. The company updated labels and software, replaced devices for free, and accrued about US$9.68 million (about RMB 68.05 million) in recall costs.

  Source

Read more

• 2020.03.26

  Reported2020.03.26

  Sanbio and its diabetes charity foundation donate COVID-19 test kits[8]三诺生物及其糖尿病公益基金会捐赠新冠检测试剂盒hn.rednet.cn

  Sanbio and the Hunan Sanwo Diabetes Charity Foundation donated 5,000 COVID-19 antibody test kits to the Italian Red Cross and separately donated 1,000 kits to Argentina’s Ministry of Health.

Read more

1. 1Sinocare Home Medical Blood Glucose and Uric Acid Meter Brand - Sinocare Official Websitesinocare.com
2. 2Sinocare Home Medical Blood Glucose and Uric Acid Meter Brand - Sinocare Official Websitesinocare.com
3. 3Sinocare Home Medical Blood Glucose and Uric Acid Meter Brand - Sinocare Official Websitesinocare.com
4. 4Sinocare Home Medical Blood Glucose and Uric Acid Meter Brand - Sinocare Official Websitesinocare.com
5. 5U.S. subsidiary's glucose meters classified by FDA as Class I recallstatic.cninfo.com.cn
6. 6U.S. subsidiary's glucose meters classified by FDA as Class I recalljiemian.com
7. 7U.S. subsidiary's glucose meters classified by FDA as Class I recallfinance.sina.com.cn
8. 8三诺生物及其糖尿病公益基金会捐赠新冠检测试剂盒hn.rednet.cn